Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.

Parikh CR, Liu C, Mor MK, Palevsky PM, Kaufman JS, Thiessen Philbrook H, Weisbord SD.

Am J Kidney Dis. 2019 Sep 20. pii: S0272-6386(19)30886-8. doi: 10.1053/j.ajkd.2019.06.011. [Epub ahead of print]

PMID:
31547939
2.

Clinical Trial Data Sharing: The Time Is Now.

Briggs JP, Palevsky PM.

J Am Soc Nephrol. 2019 Sep;30(9):1556-1558. doi: 10.1681/ASN.2019070731. Epub 2019 Aug 13. No abstract available.

PMID:
31409728
3.

Performance Measurement and the Kidney Quality Improvement Registry.

Fischer MJ, Palevsky PM.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1261-1263. doi: 10.2215/CJN.03180319. Epub 2019 Jun 10. No abstract available.

PMID:
31182555
5.

Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationale.

Mutter M, Martin M, Yamamoto Y, Biswas A, Etropolski B, Feldman H, Garg A, Gourlie N, Latham S, Lin H, Palevsky PM, Parikh C, Moreira E, Ugwuowo U, Wilson FP.

BMJ Open. 2019 Jun 1;9(5):e025117. doi: 10.1136/bmjopen-2018-025117.

6.

Quality Improvement Goals for Acute Kidney Injury.

Kashani K, Rosner MH, Haase M, Lewington AJP, O'Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):941-953. doi: 10.2215/CJN.01250119. Epub 2019 May 17.

PMID:
31101671
7.

Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury.

Liang KV, Zhang JH, Palevsky PM.

BMC Nephrol. 2019 Mar 6;20(1):82. doi: 10.1186/s12882-019-1272-7.

8.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Mar;30(3):493-504. doi: 10.1681/ASN.2018100979. Epub 2019 Feb 8.

PMID:
30737269
9.

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.

Garcia S, Bhatt DL, Gallagher M, Jneid H, Kaufman J, Palevsky PM, Wu H, Weisbord SD; PRESERVE Trial Group.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2254-2261. doi: 10.1016/j.jcin.2018.07.044.

PMID:
30466822
10.

Intravenous Fluids: Finding the Right Balance.

Palevsky PM.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1912-1914. doi: 10.2215/CJN.07850618. Epub 2018 Nov 6. No abstract available.

PMID:
30401735
11.

Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.

Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM; EUPHRATES Trial Investigators.

JAMA. 2018 Oct 9;320(14):1455-1463. doi: 10.1001/jama.2018.14618.

12.

Continuous Renal Replacement Therapy: Who, When, Why, and How.

Tandukar S, Palevsky PM.

Chest. 2019 Mar;155(3):626-638. doi: 10.1016/j.chest.2018.09.004. Epub 2018 Sep 25. Review.

13.

Net ultrafiltration intensity and mortality in critically ill patients with fluid overload.

Murugan R, Balakumar V, Kerti SJ, Priyanka P, Chang CH, Clermont G, Bellomo R, Palevsky PM, Kellum JA.

Crit Care. 2018 Sep 24;22(1):223. doi: 10.1186/s13054-018-2163-1.

14.

Endpoints for Clinical Trials of Acute Kidney Injury.

Palevsky PM.

Nephron. 2018;140(2):111-115. doi: 10.1159/000493203. Epub 2018 Sep 11. Review.

15.

Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients.

Yu LR, Sun J, Daniels JR, Cao Z, Schnackenberg L, Choudhury D, Palevsky PM, Ma JZ, Beger RD, Portilla D.

Kidney Int Rep. 2018 May 3;3(5):1202-1213. doi: 10.1016/j.ekir.2018.04.012. eCollection 2018 Sep.

16.

Global epidemiology and outcomes of acute kidney injury.

Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J, Chawla LS.

Nat Rev Nephrol. 2018 Oct;14(10):607-625. doi: 10.1038/s41581-018-0052-0. Review.

PMID:
30135570
17.

Effect of Frequent Dialysis on Renal Recovery: Results From the Acute Renal Failure Trial Network Study.

Vijayan A, Delos Santos RB, Li T, Goss CW, Palevsky PM.

Kidney Int Rep. 2017 Dec 6;3(2):456-463. doi: 10.1016/j.ekir.2017.11.018. eCollection 2018 Mar.

18.

Angiography with Sodium Bicarbonate and Acetylcysteine.

Weisbord SD, Gallagher M, Palevsky PM.

N Engl J Med. 2018 May 3;378(18):1749. doi: 10.1056/NEJMc1803605. No abstract available.

PMID:
29719175
19.

Identification of Patients Expected to Benefit from Electronic Alerts for Acute Kidney Injury.

Biswas A, Parikh CR, Feldman HI, Garg AX, Latham S, Lin H, Palevsky PM, Ugwuowo U, Wilson FP.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):842-849. doi: 10.2215/CJN.13351217. Epub 2018 Mar 29.

20.

Design and Rationale for the Veterans Affairs "Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat" Trial.

Timilsina S, Brittan K, O'Dell JR, Brophy M, Davis-Karim A, Henrie AM, Neogi T, Newcomb J, Palevsky PM, Pillinger MH, Pittman D, Taylor TH, Wu H, Mikuls TR.

Contemp Clin Trials. 2018 May;68:102-108. doi: 10.1016/j.cct.2018.03.015. Epub 2018 Mar 27.

PMID:
29597007
21.

Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1113-1123. doi: 10.2215/CJN.06820617. Epub 2018 Mar 9.

22.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.

23.

Acute renal replacement therapy during hospitalization: Is training adequate?

Palevsky PM.

Semin Dial. 2018 Mar;31(2):135-139. doi: 10.1111/sdi.12669. Epub 2018 Jan 14. Review.

PMID:
29333659
24.

Electronic Alerts for Acute Kidney Injury.

Palevsky PM.

Am J Kidney Dis. 2018 Jan;71(1):1-2. doi: 10.1053/j.ajkd.2017.09.009. No abstract available.

PMID:
29273153
25.

Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis.

Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1017-1024. doi: 10.1093/ndt/gfx308.

PMID:
29186517
26.

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.

Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group.

N Engl J Med. 2018 Feb 15;378(7):603-614. doi: 10.1056/NEJMoa1710933. Epub 2017 Nov 12.

27.

What endpoints should not be used for clinical studies of acute kidney injury?

Palevsky PM, Liu KD.

Intensive Care Med. 2018 Mar;44(3):363-365. doi: 10.1007/s00134-017-4841-x. Epub 2017 May 20. No abstract available.

28.

Predictors and outcomes of non-adherence in patients receiving maintenance hemodialysis.

Tohme F, Mor MK, Pena-Polanco J, Green JA, Fine MJ, Palevsky PM, Weisbord SD.

Int Urol Nephrol. 2017 Aug;49(8):1471-1479. doi: 10.1007/s11255-017-1600-4. Epub 2017 Apr 28.

29.

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.

Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA; Acute Disease Quality Initiative Workgroup 16.

Nat Rev Nephrol. 2017 Apr;13(4):241-257. doi: 10.1038/nrneph.2017.2. Epub 2017 Feb 27.

PMID:
28239173
30.

Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers.

Pena-Polanco JE, Mor MK, Tohme FA, Fine MJ, Palevsky PM, Weisbord SD.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):298-303. doi: 10.2215/CJN.07720716. Epub 2017 Jan 26.

31.

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction.

Palevsky PM.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2078. No abstract available.

32.

Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade.

Palevsky PM, Zhang JH, Seliger SL, Emanuele N, Fried LF; VA NEPHRON-D Study.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1944-1953. Epub 2016 Sep 27.

33.

RRT in AKI: Start Early or Wait?

Liu KD, Palevsky PM.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1867-1871. doi: 10.2215/CJN.06690616. Epub 2016 Sep 26. No abstract available.

34.

Decreasing Prevalence of Chronic Kidney Disease in the United States: A Cause for Optimism.

Fried LF, Palevsky PM.

Ann Intern Med. 2016 Oct 4;165(7):521-522. doi: 10.7326/M16-1649. Epub 2016 Aug 2. No abstract available. Erratum in: Ann Intern Med. 2017 May 2;166(9):687.

PMID:
27479750
35.

Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.

Mc Causland FR, Asafu-Adjei J, Betensky RA, Palevsky PM, Waikar SS.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1335-42. doi: 10.2215/CJN.10991015. Epub 2016 Jul 22.

36.

Prevention of Contrast-Associated Acute Kidney Injury: What Should We Do?

Weisbord SD, Palevsky PM.

Am J Kidney Dis. 2016 Oct;68(4):518-521. doi: 10.1053/j.ajkd.2016.05.005. Epub 2016 May 25. No abstract available.

PMID:
27233380
37.

Design of Clinical Trials in Acute Kidney Injury: Lessons from the Past and Future Directions.

Weisbord SD, Palevsky PM.

Semin Nephrol. 2016 Jan;36(1):42-52. doi: 10.1016/j.semnephrol.2016.01.004. Review.

PMID:
27085734
38.

Prevention Strategies for Contrast-Induced Nephropathy.

Weisbord SD, Palevsky PM.

Ann Intern Med. 2016 Apr 5;164(7):511. doi: 10.7326/L16-0098. No abstract available.

PMID:
27043990
39.

Modality of RRT and Recovery of Kidney Function after AKI in Patients Surviving to Hospital Discharge.

Liang KV, Sileanu FE, Clermont G, Murugan R, Pike F, Palevsky PM, Kellum JA.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):30-8. doi: 10.2215/CJN.01290215. Epub 2015 Dec 17.

40.

High-Volume Hemofiltration in Post-Cardiac Surgery Shock. A Heroic Therapy?

Palevsky PM.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1143-4. doi: 10.1164/rccm.201508-1561ED. No abstract available.

PMID:
26568234
41.

BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.

Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF; VA NEPHRON-D Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19.

42.

Contrast-associated Acute Kidney Injury.

Weisbord SD, Palevsky PM.

Crit Care Clin. 2015 Oct;31(4):725-35. doi: 10.1016/j.ccc.2015.06.008. Epub 2015 Jul 29. Review.

PMID:
26410140
43.

The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock.

Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC; ProCESS and ProGReSS-AKI Investigators.

Am J Respir Crit Care Med. 2016 Feb 1;193(3):281-7. doi: 10.1164/rccm.201505-0995OC.

44.

A new CJASN series: renal immunology for the clinician.

Lakkis FG, Palevsky PM.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1273. doi: 10.2215/CJN.03870415. No abstract available.

45.

Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT.

Pike F, Murugan R, Keener C, Palevsky PM, Vijayan A, Unruh M, Finkel K, Wen X, Kellum JA; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1332-9. doi: 10.2215/CJN.09911014. Epub 2015 Jun 5.

46.

Perioperative Pharmacologic Management of Patients with End Stage Renal Disease.

Karambelkar A, Kasekar R, Palevsky PM.

Semin Dial. 2015 Jul-Aug;28(4):392-6. doi: 10.1111/sdi.12384. Epub 2015 Apr 15. Review.

PMID:
25876523
47.

Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.

Murugan R, Wen X, Keener C, Pike F, Palevsky PM, Unruh M, Finkel K, Vijayan A, Elder M, Chen YF, Kellum JA; Biological Markers of Recovery for the Kidney (BioMaRK) Study Investigators.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):926-33. doi: 10.2215/CJN.04560514. Epub 2015 Apr 10.

48.

Longitudinal associations of depressive symptoms and pain with quality of life in patients receiving chronic hemodialysis.

Belayev LY, Mor MK, Sevick MA, Shields AM, Rollman BL, Palevsky PM, Arnold RM, Fine MJ, Weisbord SD.

Hemodial Int. 2015 Apr;19(2):216-24. doi: 10.1111/hdi.12247. Epub 2014 Nov 18.

49.

Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis.

Weisbord SD, Mor MK, Sevick MA, Shields AM, Rollman BL, Palevsky PM, Arnold RM, Green JA, Fine MJ.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1594-602. doi: 10.2215/CJN.00220114. Epub 2014 Jul 31.

50.

A new CJASN series: Renal physiology for the clinician.

Zeidel ML, Hoenig MP, Palevsky PM.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1271. doi: 10.2215/CJN.10191012. No abstract available.

Supplemental Content

Loading ...
Support Center